Lv2
200 积分 2023-09-08 加入
Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay)
2天前
已完结
Neurokinin receptor antagonism: a patent review (2014-present)
5天前
已完结
Structure-activity relationship of neurokinin A(4–10) at the human tachykinin NK2 receptor: the effect of amino acid substitutions on receptor affinity and function
5天前
已完结
NK2R control of energy expenditure and feeding to treat metabolic diseases
7天前
已完结
NK2R control of energy expenditure and feeding to treat metabolic diseases
9天前
已完结
（高分）求补充材料：LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
12天前
已完结
The CRF/Urocortin systems as therapeutic targets for alcohol use disorders
13天前
已完结
The CRF/Urocortin systems as therapeutic targets for alcohol use disorders
13天前
已关闭
TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3–Related Skeletal Dysplasias
15天前
已完结
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
20天前
已完结
皖公网安备34019202002308
